21 - 136 - TUBEROUS SCLEROSIS COMPLEX Flashcards

1
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
26
Major features of TS, except a. Hypomelanotic macules >3 atleast 5 cm in diameter b. Shagreen patch c. Ungual fibromas >2 d. Angiofibromas >3
a. Hypomelanotic macules >3 atleast 5 cm in diameter
27
Minor features of TS, except a. Confetti skin lesions b. Dental enamel pits >2 c. Intraoral fibromas >2 d. Multiple renal cysts
b. Dental enamel pits >2
28
Indications for use of mTOR inhibitors for TS, except a. cardiac rhabdomyomas b. LAM c. Angiomyolipomas d. Angiofibromas
d. Angiofibromas
29
Skin manifestation that is associated with ipsilateral cerebral abnormalities and contralateral seizures a. Shagreen patch b. Fibrous plaque c. Koenen tumor d. Angiofibromas
b. Fibrous plaque
30
Less common affected area by shagreen patch a. Lower back - MC b. Sacral region - MC c. Upper Back d. Forehead
c. Upper Back
31
pattern of inheritance of TSC
AD
32
Tuberous sclerosis complex (TSC) is a genetic disease caused by mutations in what tumor-suppressor gene?
TSC1 or TSC2
33
tuberous sclerosis complex affect what organs?
brain, heart, kidneys, lungs, and skin.
34
common presentation of TSC during infancy
seizures
35
skin findings of patients with TSC
* hypomelanotic macules * facial angiofibromas * fibrous cephalic plaques * shagreen patches, * ungual fibromas
36
what is the major criteria for hypomelanotic macules
**Three or more hypopigmented macules measuring 5 mm or greater in longest dimension** constitutes a major feature for the diagnosis of tuberous sclerosis
37
AOP of ash-leaf spots
trunk and buttocks
38
AOP of confetti skin lesions
legs below the knees or forearms
39
AOP of facial angiofibromas
**central face** and are often concentrated in the **alar grooves** ## Footnote extending symmetrically onto the cheeks and to the nose, nasal opening, and chin, with relative sparing of the upper lip and lateral face
40
angiofibromas relatively spare what areas of the face?
upper lip and lateral face
41
how many angiofibromas comprise a major feature?
3 or more
42
The development of multiple angiofibromas with onset later in adolescence or early adulthood is not specific for TSC and may, instead, indicate presence of what conditions?
multiple endocrine neoplasia Type 1 or Birt-Hogg-Dubé syndrome
43
Most common location of shagreen patch
lower back to sacral region
44
how many ungual fibromas should be present for it to be classified as a major feature for diagnosis of TSC?
2 or more
45
another name for multiple skin tags in tuberous sclerosis complex
Molluscum fibrosum pendulum
46
intraoral fibromos are most common on what site?
gingiva
47
The first-line treatment of infantile spasms
vigabatrin
48
This drug inhibits mTORC1 activity and treats TSC tumors
Sirolimus (rapamycin)
49
Lesions characteristic of TSC
* Juvenile-Onset Angiofibromas (≥3) * Hypomelanotic Macules (≥3) * Ungual Fibromas (≥2) * Fibrous Cephalic Plaque * Shagreen Patch
50
clinical course and prognosis of TSC
* They exhibit **decreased overall survival **compared with the general population. * The causes of premature death include** renal failure, intractable seizures, obstructive hydrocephalus, cardiac outflow obstruction, arrhythmia, respiratory failure, pneumothorax, and hemorrhage** from an aneurysm or a tumor, especially angiomyolipomas * Brain and heart tumors may cause death in infancy, whereas lung and kidney tumors are more likely to cause premature death in adulthood. * **The prognosis for the individual patient depends on disease expressivity.** * Some individuals have a normal life span with few medical complications.
51
The management of TSC skin tumors has changed with the use of what drug classification?
mTOR inhibitors ## Footnote Everolimus, Sirolimus